Sadly I think your hopes will be dashed.
Save yourself time, there’s no update trial- wise coz there are no trials.
Hey you can ask company directly what’s happened, and here’s good question: ask them when this class of therapy (il8 inhibitor) has been extensively researched and abandoned by big Pharma, why dimx think they have something big Pharma missed and will achieve different outcome?
>>>>would love to know what response you get and share on this forum. Good luck.
DXB - Research & Valuation, page-149
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.010(2.27%) |
Mkt cap ! $236.7M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 42.0¢ | $715.3K | 1.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 121 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 21190 | 1 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |